13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 69 holding rows worth $6,774,577,416.
- Accession
- 0001493152-24-019465
- Filer
- CIK 1493215
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 69 entries on the cover page, a total value of $6,774,577,416 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,774,577,416 with VALUE read as dollars as filed, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 17,687,772 | $476,508,578 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 6,019,641 | $391,276,665 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 4,492,679 | $358,515,784 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 7,087,115 | $330,897,399 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 3,344,095 | $314,144,284 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 667,195 | $262,688,015 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 13,829,315 | $255,704,034 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 2,593,323 | $237,185,322 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 7,423,970 | $215,963,287 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 1,462,400 | $214,753,440 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 7,970,269 | $203,401,264 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 4,109,393 | $185,045,967 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,525,080 | $177,033,359 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 2,467,591 | $163,971,422 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 6,054,280 | $163,889,360 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 5,315,514 | $153,777,820 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 675,888 | $150,844,684 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 8,798,558 | $148,607,645 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 5,431,985 | $137,211,941 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 2,675,703 | $136,193,283 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 3,297,897 | $136,137,188 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 3,272,341 | $118,949,595 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 321,000 | $114,876,270 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 397,047 | $106,027,431 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 10,000,000 | $105,100,000 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 5,480,577 | $102,706,013 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 288,684 | $94,004,171 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 3,091,587 | $87,770,155 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 7,378,548 | $85,886,299 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,232,760 | $84,688,586 | dollars as filed | |
| VERICEL CORP | 92346J108 | COM | 1,606,397 | $83,564,772 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 3,735,619 | $83,379,016 | dollars as filed | |
| RADNET INC | 750491102 | COM | 1,700,550 | $82,748,763 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 110,500 | $64,223,705 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 1,554,856 | $58,353,746 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 4,224,838 | $57,035,313 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 5,845,956 | $55,185,825 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 18,593,185 | $53,362,441 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,865,108 | $50,600,380 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 3,257,347 | $48,860,205 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 1,852,711 | $46,021,341 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 99,000 | $39,509,910 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 769,122 | $39,148,310 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 1,000,000 | $37,650,000 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 3,327,129 | $35,467,195 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 5,620,640 | $29,620,773 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 666,667 | $20,000,010 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,298,662 | $19,515,640 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 863,389 | $19,279,476 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 413,670 | $18,160,113 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 741,656 | $16,983,922 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,454,273 | $15,328,037 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 605,816 | $10,607,838 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 4,134,631 | $9,716,383 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 350,000 | $7,374,500 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 978,310 | $6,603,593 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 95,000 | $6,560,700 | dollars as filed | |
| NULL | 02008G102 | NULL | 3,457,707 | $6,050,987 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 4,567,717 | $6,029,386 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 3,256,102 | $5,828,423 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 58,791 | $5,543,403 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 999,147 | $5,415,377 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 650,000 | $4,933,500 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 917,827 | $4,166,934 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 1,504,602 | $2,392,317 | dollars as filed | |
| BEYOND AIR INC | 08862L103 | COM | 1,204,820 | $2,096,387 | dollars as filed | |
| CUTERA INC | 232109108 | COM | 1,331,776 | $1,957,711 | dollars as filed | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 127,970 | $1,437,103 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 350,000 | $104,720 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-24-019465 | this filing | 2024-05-15 | acceptance time not in the bulk data set |